Literature DB >> 8399324

Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cells.

S Furukawa1, T Hirano.   

Abstract

Intracellular cholesteryl ester (CE) biosynthesis is thought to play an important role in the secretion of apolipoprotein (apo) B from hepatocytes. We have reported that oleate rapidly increased apo B secretion by suppressing early intracellular degradation of nascent apo B in HepG2 cells. The aim of the present study is to determine whether the rapid stimulatory effect of oleate on apo B secretion is associated with CE biosynthesis. Oleate (0.4 mM) rapidly and strikingly increased triacylglycerol (TG) but not CE in the cells and the medium. Apo B was linearly secreted into the medium during 180 min and oleate doubled the rate of secretion. Fluvastatin, a newly synthesized 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, or 25-hydroxycholesterol did not alter the apo B secretion rate, although the former suppressed and the latter stimulated CE production in the cells. Pulse-chase studies revealed that neither fluvastatin or 25-hydroxycholesterol treatments affected apo B production or intracellular degradation of newly synthesized apo B. These results suggest that, at least in short-term incubation, the modulation of CE biosynthesis does not alter apo B kinetics in HepG2 cells. Therefore, we concluded that rapid stimulation of apo B secretion by oleate is not associated with CE biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399324

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin.

Authors:  N M Borradaile; K K Carroll; E M Kurowska
Journal:  Lipids       Date:  1999-06       Impact factor: 1.880

2.  Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.

Authors:  M R Peluso; J L Dixon
Journal:  Lipids       Date:  1997-08       Impact factor: 1.646

Review 3.  Pathophysiology of Diabetic Dyslipidemia.

Authors:  Tsutomu Hirano
Journal:  J Atheroscler Thromb       Date:  2018-07-12       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.